Effects of reduced exposure to cigarette smoking on changes in biomarkers of potential harm in adult smokers: results of combined analysis of two clinical studies. (4th July 2019)

• Record Type: Journal Article
• Authors: Sakaguchi, Chikako; Miura, Naoki; Ohara, Hiromi; Nagata, Yasufumi
• Is Part Of: Biomarkers. Volume 24:Number 5(2019)
• Page Start: 457
• Page End: 468
• Publication Date: 2019-07-04
• Subjects: Smoking -- biomarker of potential harm -- biomarker of exposure -- nonconventional vapor product -- noncombustion and nonheating inhaler type of smokeless tobacco product; Biochemical markers -- Periodicals; 610.28
• DOI: 10.1080/1354750X.2019.1609579
• Languages: English
• ISSNs: 1354-750X

Abstract

Abstract: Purpose: Nonconventional vapor products (NVP), designed to reduce exposure to cigarette smoke toxicants (CSTs), could cause changes in biomarkers of potential harm (BoPH). Although, NVPs reduced CSTs exposure compared to conventional cigarettes (CC), the changes in the BoPH values varied among the studies. Hence, further information on BoPH using NVPs is needed. Material and methods: The data of two similarly designed studies using a kind of NVP, a noncombustion and nonheating inhaler type of smokeless tobacco product (NCIT) used under 31-day confinement, were pooled, and the differences in 15 BoPH between smokers and nonsmokers at baseline and between the 1 mg tar CC (CC1) group and NCIT group at Day 28/29 were analyzed. Results: At baseline, the levels of eight BoPH (red blood cells, white blood cells, 8-epi-prostaglandin F2α, 8-hydroxy-2′-deoxyguanosine, malondialdehyde, 11-dehydrothromboxane B2, total cholesterol and glucose) were significantly different between smokers and nonsmokers. At Day 28/29, the levels of six BoPH were significantly different between NCIT and CC1 (8-epi-prostaglandin F2α, malondialdehyde, 11-dehydrothromboxane B2: CC1 > NCIT, total bilirubin, low-density lipoprotein cholesterol and total cholesterol: CC1 < NCIT). Conclusions: Reduced exposure to CSTs has favorable effects on BoPH associated with oxidative stress, antioxidant capacity and platelet activation/coagulation but not in lipid metabolism.